Aggregating investigators, patients and private entities to develop better therapies through efficient and patient-centered clinical trials
Joined November 2025
- Tweets21
- Following124
- Followers161
- Likes27
CoMMit-Myeloma Trial Innovated retweeted
Don’t know about other but in my academic practice, I am fortunate to care for ~ 70-75 myeloma patients weekly! I love it and patient care remains my “top” priority!
CoMMit publication alert! Patients with standard risk NDMM and 12-month sustained MRD negativity and NO further therapy have ~2.5% year risk of progression!!
nature.com/articles/s41375-0…
This paradigm-challenging trial is 💯 accrued! Congratulations to the sites, investigators, staff and our gratitude to patients. @bhemato @ldandersonjr @nsc_natalie @SusanBal9 @CBCIDocs @rajshekharucms @huntsmanMM @RahulBanerjeeMD @DholariaMD @MMBaljevicMD @End_myeloma
CoMMit-Myeloma Trial Innovated retweeted
IMWG recommendatons for Solitary Plasmacytoma JCO @myelomaMD @VincentRK @chngwj @End_myeloma @dra_v_hungria @JHillengass @sykristinsson @SagarLonialMD @EliasKarlMai @TomMartinMD @jmikhaelmd @NikhilMunshiMD @BrunoPaiva_UNAV @_DrCP @RascheLeo @JoshuaRichterMD @szusmani @thanosdimop
CoMMit Publication- Redefining FHR MM in the context of upfront QUAD- Ravi - 2026 - Cancer - Wiley Online Library acsjournals.onlinelibrary.wi…
Last call! We are approaching completion of accrual for this paradigm-challenging trial! @bhemato @ldandersonjr @DholariaMD @HealthTree @RahulBanerjeeMD @ColoradoBlood @rajshekharucms @huntsmanMM @OHSUKnight @SusanBal9 @MMBaljevicMD
CoMMit-Myeloma Trial Innovated retweeted
Together we have accrued>160 #mmsm patients to transformative CoMMit trials in 2025!! Breakthroughs are on reach, and it will need your support. Please donate commitmyelomatrials.org
CoMMit-Myeloma Trial Innovated retweeted
I believe second milestone is clear. we must do the work to finish the journey. #mmsm @ESHaematology @CoMMitTrials
***COMMIT Publication Alert***
British Journal of Haematology | Wiley Online Library onlinelibrary.wiley.com/doi/…
**CoMMit Publication** Distinct trajectory of measurable residual disease in t(11;14) myeloma treated with quadruplet therapy ashpublications.org/blood/ar…
Together we have accrued>160 #mmsm patients to transformative CoMMit trials in 2025!! Breakthroughs are on reach, and it will need your support. Please donate commitmyelomatrials.org
CoMMit-Myeloma Trial Innovated retweeted
In @CoMMitTrials we are testing Tec-Dara as consolidation-maintenance, fixed duration, steroid free. Hoping to prevent progression from happening in first place. @MyelomaTeacher @grpetersen1
Original Article: Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma (MajesTEC-3 phase 3 trial) nej.md/4431DUD
#ASH25 | @ASH_hematology
ALT The Kaplan–Meier estimate of overall survival at 36 months among the patients in the teclistamab–daratumumab group and the DPd or DVd group
CoMMit-Myeloma Trial Innovated retweeted
#ASH25 not many investigator meetings look like this, but the @CoMMitTrials meeting thanks to @End_myeloma!
🍷 not shown, nor the 🛩️ Luciano has earned.
Look for many innovative trial results coming soon, including MASTER-2 with MRD-guided decision-making!
Productive evening conspiring against myeloma. This fantastic group accrued >150 patients in MM treatment trials in 2025. Several key colleagues couldn't make to MCO, will join us next year.
Commit crew dissecting #ASH25 data and planing the next generation of myeloma trials. Let's keep pushing! @RahulBanerjeeMD
Happy Giving Tuesday! Get to know our group and our mission and, if you like it, consider giving your support. commitmyelomatrials.org
All CoMMit active trials and past research is now in one place. Learn more about and support our work. commitmyelomatrials.org